Lauren Jean Oshry, MD
Assistant Professor, Medicine
Biography
Dr. Lauren Oshry is an Assistant Professor of Medicine at the Chobanian and Avedisian School of Medicine and a member of the section of Hematology and Oncology at Boston Medical Center. She is a Phi Beta Kappa graduate of Wellesley College and an Alpha Omega Alpha graduate of the Albert Einstein College of Medicine. She completed her internship and residency at Boston City Hospital and fellowship training in Hematology and Oncology at Beth Israel Hospital/Harvard Medical School, after which she joined the faculty of Chobanian and Avedisian School of Medicine. She has a special interest in breast and gynecologic cancers, with a focus on disparities in care as well as lifestyle modifications, including weight management and exercise, to improve outcomes.
Other Positions
- Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
- East Boston Neighborhood Health Center
Education
- Albert Einstein College of Medicine, MD
- Wellesley College, BA
Publications
- Published on 1/16/2025
Oshry LJ, Lederman RI, Gagnon H, Fikre T, Gundersen DA, Revette AC, Odai-Afotey A, Kantor O, Hershman DL, Crew KD, Keating NL, Freedman RA, Ko NY. Racial discrimination among women seeking breast cancer care. NPJ Breast Cancer. 2025 Jan 16; 11(1):4. PMID: 39819887.
Read at: PubMed - Published on 9/20/2024
Ko N, Oshry L, Lederman R, Gagnon H, Fikre T, Gundersen D, Revette A, Odai-Afotey A, Kantor O, Hershman D, Crew K, Keating N, Freedman R. See Me, Hear Me: Racial Discrimination Among Women Seeking Breast Cancer Care. Res Sq. 2024 Sep 20. PMID: 39372929.
Read at: PubMed - Published on 1/30/2023
Medford AJ, Oshry L, Boyraz B, Kiedrowski L, Menshikova S, Butusova A, Dai CS, Gogakos T, Keenan JC, Occhiogrosso RH, Ryan P, Lennerz JK, Spring LM, Moy B, Ellisen LW, Bardia A. TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis. Ther Adv Med Oncol. 2023; 15:17588359231152844. PMID: 36743521.
Read at: PubMed - Published on 12/1/2020
Lombardi FL, Jafari N, Bertrand KA, Oshry LJ, Cassidy MR, Ko NY, Denis GV. Novel semi-automated algorithm for high-throughput quantification of adipocyte size in breast adipose tissue, with applications for breast cancer microenvironment. Adipocyte. 2020 12; 9(1):313-325. PMID: 32633194.
Read at: PubMed - Published on 9/4/2020
Ko NY, Qureshi MM, Oladeru OT, Cassidy MR, Oshry L, Truong MT, Hirsch AE. Racial differences in genomic testing and receipt of endocrine therapy in early-stage breast cancer. Breast Cancer Res Treat. 2020 Dec; 184(3):849-859. PMID: 32888137.
Read at: PubMed - Published on 6/1/2020
Festa K, Hirsch AE, Cassidy MR, Oshry L, Quinn K, Sullivan MM, Ko NY. Breast Cancer Treatment Delays at an Urban Safety Net Hospital Among Women Experiencing Homelessness. J Community Health. 2020 06; 45(3):452-457. PMID: 31625050.
Read at: PubMed - Published on 1/14/2020
Kim KN, Qureshi MM, Huang D, Ko NY, Cassidy M, Oshry L, Hirsch AE. The Impact of Locoregional Treatment on Survival in Patients With Metastatic Breast Cancer: A National Cancer Database Analysis. Clin Breast Cancer. 2020 04; 20(2):e200-e213. PMID: 32089454.
Read at: PubMed - Published on 1/1/2020
Yates PA, Newman SA, Oshry LJ, Glassman RH, Leone AM, Reichel E. Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease. Ther Adv Respir Dis. 2020 Jan-Dec; 14:1753466620951053. PMID: 32873175.
Read at: PubMed - Published on 8/15/2019
Quintiliani LM, Foster M, Oshry LJ. Preferences of mHealth app features for weight management among breast cancer survivors from underserved populations. Psychooncology. 2019 10; 28(10):2101-2104. PMID: 31368197.
Read at: PubMed - Published on 1/1/2017
Crawford C, Oshry LJ, Reichel E. ATYPICAL MACULOPATHY IN A PATIENT WITH LIGHT CHAIN DEPOSITION DISEASE MIMICKING ADVANCED GEOGRAPHIC ATROPHY. Retin Cases Brief Rep. 2017 Winter; 11(1):83-85. PMID: 26934302.
Read at: PubMed
View 6 more publications: View full profile at BUMC